High versus standard doses of corticosteroids in severe COVID-19: a retrospective cohort study

Despite the increasing evidence of the benefit of corticosteroids for the treatment of moderate-severe coronavirus disease 2019 (COVID-19) patients, no data are available about the potential role of high doses of steroids for these patients. We evaluated the mortality, the risk of need for mechanica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Eur J Clin Microbiol Infect Dis
Hauptverfasser: Monreal, Enric, Sainz de la Maza, Susana, Natera-Villalba, Elena, Beltrán-Corbellini, Álvaro, Rodríguez-Jorge, Fernando, Fernández-Velasco, Jose Ignacio, Walo-Delgado, Paulette, Muriel, Alfonso, Zamora, Javier, Alonso-Canovas, Araceli, Fortún, Jesús, Manzano, Luis, Montero-Errasquín, Beatriz, Costa-Frossard, Lucienne, Masjuan, Jaime, Villar, Luisa María
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer Berlin Heidelberg 2020
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7575217/
https://ncbi.nlm.nih.gov/pubmed/33083917
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10096-020-04078-1
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge